Proteomic study on protective mechanism of ischemic preconditioning to ischemia-reperfusion lung injury

Abstract

Objective To investigate the change of protein expression of lung tissue of rabbit after ischemic preconditioning (IP) and try to elucidate the potential protective mechanism of IP. Methods 12 domestic rabbits were randomly divided into group IP and group control (6 rabbits in each group). All the left lungs were afflicted by ische mia-reperfusion injury except that those in group IP were subject to IP prior to ischemic phase. 2-DE was employed to separate the total protein of the lung tissue. PDQuest analysis software was used to distinguish the differently expressed protein spot. MALDI-TOF-MS and Mascot database searching were exploited to identify these proteins. Results 1) IP attenuated the ischemia-reperfusion lung injury. 2) The proteomic analysis showed 35 target proteins, of which 17 were characterized such as phosphatidylinositol 3-kinase(PI3k) delta catalytic subunit. Conclusions 1) Proteomic is a promising tool to investigate the IP and ischemia-reperfusion lung injury. 2) That IP inhibits inflammatory cascades through phosphatidylinositol 3-kinase signal transduction pathway may be one of its protective mechanism.

Keywords

proteome / ischemic preconditioning / ischemia-reperfusion injury / phosphatidylinositol 3-kinase

References

[1] GorgA, ObermaierC, BoguthG, et al.. The current state of two dimensional electrophoresis with immobilized pH gradients[J]. Electrophoresis, 2000, 21(6): 1037-1053

[2] SiemionowM, ArslanE. Ischemia/reperfusion injury: a review in releation to free tissue transfers[J]. Microsurgery, 2004, 24(6): 468-475

[3] AlexiouC, TangA A, SheppardS V, et al.. The effect of leucodepletion on leucocyte activation, pulmonary inflammation and respiratory index in surgery for coronary revascularisation: a prospective randomised study[J]. Eur J Cardiothorac Surg, 2004, 26(2): 294-300

[4] ZhangChun-fang, ChenSheng-xi, LuoWan-jun. Protective effects of ischemic preconditioning to the lung injury during the isolated lung perfusion[J]. Chin J Exp Surg, 2004, 21: 1253-1254(in Chinese)

[5] ZhangChun-fang, ChenSheng-xi, GuoHai-zhou, et al.. protective mechanism of ischemic preconditioning to the lung ischemis-reperfusion injury[J]. J Cent South Univ(Med Sci), 2005, 30(1): 64-67(in Chinese)

[6] MadonnaR, PandolfiA, MassaroM, et al.. Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase[J]. Diabetologia, 2004, 47(3): 532-536

[7] OuditG Y, SunHui, KerfantB G, et al.. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease[J]. J Mol Cell Cardiol, 2004, 37(2): 449-471

[8] Wymann M P, Zvelebil M, Laffargue M. Phosphoinositide 3-kinase signalling—which way to target?[J]. Trend Pharmacol Sci, 2003, (24): 366 – 376.

[9] WetzkerR, RommelC. Phosphoinositide 3-kinases as targets for therapeutic intervention[J]. Curr Pharm Des, 2004, 10(16): 1915-1922

[10] WalkerE H, PerisicO, RiedC, et al.. Structural insights into phosphoinositide 3-kinase catalysis and signalling[J]. Nature, 1999, 402: 313-320

[11] StockerH, AndjelkovicM, OldhamS, et al.. Living with lethal PIP3 levels: viability of flies lacking PTEN restored by a pH domain mutation in Akt/PKB[J]. Science, 2002, 295: 2088-2091

[12] SongGang, OuyangGao-liang, BaoShi-deng, et al.. The activation of Akt/PKB signaling pathway and cell survival[J]. J Cell Mol Med, 2005, 9(1): 59-71

[13] ArmstrongS C. Protein kinase activation and myocardial ischemia/reperfusion injury[J]. Cardiovascular Research, 2004, 61(3): 427-436